You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
25 March 2026 - Dutch health technology company Royal Philips (NYSE:PHG) (AEX:PHIA) on Wednesday introduced IntraSight Plus, an interventional cardiology platform cleared for clinical use in the United States and Europe, combining diagnostic and trea...
25 March 2026 - Myosin Therapeutics, a Florida-based biotechnology company, announced on Tuesday that it has been awarded USD2m in funding from the Florida Department of Health through the Casey DeSantis Florida Cancer Innovation Fund (FCIF).This fun...
25 March 2026 - Commercial-stage biotechnology company Clover Biopharmaceuticals Ltd (HKEX:02197) on Tuesday reported additional positive data from a Phase I clinical trial in the United States evaluating re-vaccination with the company's RSV Pr...
25 March 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) announced on Tuesday that it has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to commence Phase II cl...
24 March 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) said on Tuesday that they have received marketing and manufacturing authorisation in Japa...
24 March 2026 - Global healthcare company Abbott (NYSE:ABT) confirmed on Monday that it has completed the acquisition of molecular diagnostics company Exact Sciences.According to Abbott, this acquisition establishes its position as a leader in fast-g...
24 March 2026 - PANTHERx Rare Pharmacy, a specialty pharmacy focused on rare and orphan diseases, announced on Monday that it has been selected by Belgium-based biopharmaceutical company UCB (EBR:UCB) as the exclusive specialty pharmacy for the distr...